Envoy Medical
COCH
58 hedge funds and large institutions have $213M invested in Envoy Medical in 2021 Q2 according to their latest regulatory filings, with 58 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
51.56% more ownership
Funds ownership: 0% → 51.56% (+52%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nomura Holdings
Tokyo,
Japan
|
+$18.6M |
| 2 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$14.6M |
| 3 |
Goldman Sachs
New York
|
+$12.4M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$12.1M |
| 5 |
FTCM
Fir Tree Capital Management
New York
|
+$11.8M |
Top Sellers
COCH Hedge Fund Activity: Q2 2021 in Review
58 of the 5,768 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q2 2021, worth a combined $213M.
Buyers outnumbered sellers: 58 funds opened new COCH positions and 0 closed out — a net gain of 58 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Nomura Holdings, opening a new position worth an estimated $18.6M.
- 58 institutional investors held Envoy Medical (COCH) as of Q2 2021, up from 0 in Q1 2021.
- Funds reported $213M of Envoy Medical stock for Q2 2021.
- 58 funds opened new Envoy Medical positions in Q2 2021 and 0 closed out, a net change of +58 holders.
- The largest Envoy Medical buyer in Q2 2021 was Nomura Holdings, an estimated $18.6M added.
Based on aggregated 13F filings for Q2 2021.